Quick recap of why this matters on semaglutide Semaglutide, available in India as Obeda (Dr Reddys Laboratories, launched March 2026) and as Ozempic, is a GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives significant weight loss
Income, education, and neighbourhood conditions may all play a role. Neighbourhood conditions continued to affect heart health even after researchers took income and education into account
Another crucial strategy is regular exercise
Exploring the Role of p53 in Radiosensitivity: A Key Player in Cancer Therapy, Radiation , vol
We have three convenient Houston-area locations: Houston, Katy, and Webster, serving patients across Greater Houston